BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8588143)

  • 1. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study.
    Kuzman I; Soldo I; Schönwald S; Culig J
    Scand J Infect Dis; 1995; 27(5):503-5. PubMed ID: 8588143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
    Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB
    Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of pneumonia caused by Legionella with azithromycin].
    Sánchez F; Mensa J; Martínez JA; Badia R; Albarracín M; Losa JE; Ruiz M; Marcos MA; Torres A; Soriano E
    Rev Esp Quimioter; 1998 Jun; 11(2):147-51. PubMed ID: 9795300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
    Griffin AT; Peyrani P; Wiemken T; Arnold F
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
    Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE
    Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legionellosis.
    Pedro-Botet ML; Sabrià M
    Semin Respir Crit Care Med; 2005 Dec; 26(6):625-34. PubMed ID: 16388431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful.
    Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T; Fujii H; Hashimoto T; Nakajima H; Amemura-Maekawa J
    Jpn J Infect Dis; 2017 Nov; 70(6):660-662. PubMed ID: 28890505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
    J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment for Legionnaires' disease. Macrolides or quinolones?].
    Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A
    Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of azithromycin activity against Legionella spp.
    Edelstein PH
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].
    Benito JR; Montejo JM; Cancelo L; Zalacaín R; López L; Fernández Gil de Pareja J; Alonso E; Oñate J
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):394-400. PubMed ID: 14525703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on Legionella.
    Carratalà J; Garcia-Vidal C
    Curr Opin Infect Dis; 2010 Apr; 23(2):152-7. PubMed ID: 20051846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a 5 day course of azithromycin enough for infections caused by Legionella pneumophila?
    Matute AJ; Schurink CA; Hoepelman IM
    J Antimicrob Chemother; 2000 Jun; 45(6):930-1. PubMed ID: 10837459
    [No Abstract]   [Full Text] [Related]  

  • 14. Current clinical management of Legionnaires' disease.
    Garcia-Vidal C; Carratalà J
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):995-1004. PubMed ID: 17181416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
    Dunbar LM; Khashab MM; Kahn JB; Zadeikis N; Xiang JX; Tennenberg AM
    Curr Med Res Opin; 2004 Apr; 20(4):555-63. PubMed ID: 15119993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of legionnaires' disease.
    Klein NC; Cunha BA
    Semin Respir Infect; 1998 Jun; 13(2):140-6. PubMed ID: 9643392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legionella pneumonia.
    Ruggles L
    Can Fam Physician; 2001 Sep; 47():1737-9. PubMed ID: 11570298
    [No Abstract]   [Full Text] [Related]  

  • 18. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legionnaires disease with bacteremic coinfection.
    Tan MJ; Tan JS; File TM
    Clin Infect Dis; 2002 Sep; 35(5):533-9. PubMed ID: 12173126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe community-acquired legionella pneumonia: treatment, complications and outcome.
    Hubbard RB; Mathur RM; MacFarlane JT
    Q J Med; 1993 May; 86(5):327-32. PubMed ID: 8327650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.